The gonadal synthesis of testosterone from cholesterol involves four enzyme
s, namely, cytochrome P-450 side-chain cleavage enzyme, cytochrome P-450 17
alpha -hydroxylasellyase, 3 beta -hydroxysteroid dehydrogenase, and 17 bet
a -hydroxysteroid dehydrogenase. A significant part of the plasma--borne te
stosterone is converted in androgen target tissues, such as the skin, to th
e more potent androgen dihydrotestosterone by the steroid 5 alpha -reductas
e type 1 and type 2 isoenzymes. Dihydrotestosterone, which binds to the nuc
lear androgen receptor with much greater affinity than testosterone, is the
androgen responsible for a process leading to androgenetic alopecia. Conse
quently, the 5 alpha -reductase inhibitor finasteride was developed and has
proven efficacious in promoting hair growth as a consequence of lowering s
calp and plasma dihydrotestosterone levels. In contrast to the direct synth
esis of dihydrotestosterone from testosterone, biologically inactive C-19-s
teroids produced by glandular and peripheral tissues may also feed into the
scalp skin production of dihydrotestosterone by the local expression of re
ductive 17 beta -hydroxysteroid dehydrogenase, oxidative 3 alpha -hydroxyst
eroid and 3 beta -hydroxysteroid dehydrogenase enzymes. Aberrant expression
of one or more of these enzymes, could conceivably result in increased sca
lp dihydrotestosterone levels, and possibly, acceleration of the balding pr
ocess in genetically predisposed men and women.